ERBB2 and breast carcinoma: The AI algorithm also detected accurately tumor-infiltrating lymphocytes (TILs) (Fig. 2g, h and Supplementary Table 4), a prognostic marker in triple-negative and HER2-positive breast carcinomas, and identified angiolymphatic invasion (ALI) (Fig. 2i, j).